Difference between revisions of "Team:Calgary/Thymol Engineering"

 
(45 intermediate revisions by 3 users not shown)
Line 146: Line 146:
 
           /></a>
 
           /></a>
  
           <a href="#project-design">Project Designs</a>
+
           <a href="#overview">Overview</a>
 
<br>
 
<br>
           <a href="#part-design">Part Design</a>
+
           <a href="#understanding-the-problem">Understanding the Problem</a>
 
<br>
 
<br>
           <a href="#experimental-design">Experimental Design</a>
+
           <a href="#identifying-thymol">Identifying Thymol</a>
 
<br>
 
<br>
           <a href="#future-directions">Future Directions</a>
+
           <a href="#part-design">Part Design </a>
 
<br>
 
<br>
           <a href="#understanding-the-problem">Understanding the Problem</a>
+
           <a href="#experimental-design"> Experimental Design</a>
 
<br>
 
<br>
           <a href="#experimental-troubleshooting">Experimental Troubleshooting</a>
+
           <a href="#future-directions">Future Directions</a>
  
<br>
 
          <a href="#expected-results">Expected Results</a>
 
 
<br>
 
<br>
 
           <a href="#references"> References</a>
 
           <a href="#references"> References</a>
Line 178: Line 176:
 
       <!-- BODY -->
 
       <!-- BODY -->
 
       <div class="intro-body">
 
       <div class="intro-body">
<div class = "project-design" id="project-design">
+
<div class = "overview" id="overview">
 
         <h2>OVERVIEW</h2>
 
         <h2>OVERVIEW</h2>
 
<img class="img-fluid"style="width:100%;"src="https://static.igem.org/mediawiki/2020/5/5a/T--Calgary--thymolpipeline.png" />
 
<img class="img-fluid"style="width:100%;"src="https://static.igem.org/mediawiki/2020/5/5a/T--Calgary--thymolpipeline.png" />
Line 186: Line 184:
 
         <p>
 
         <p>
  
To allow our target communities to maximize micronutrient and vitamin A absorption in between deworming seasons, we will engineer our yeast to produce thymol which is naturally found in thyme leaves. This will allow our yeast consumers to alleviate damage and destroy parasitic worms in the intestines. Our initial goal is to create a proof of concept in the lab. To do this, we followed the engineering design cycle to build our project:
+
To allow our target communities to maximize micronutrient and vitamin A absorption in between deworming seasons, we will engineer our yeast to produce thymol which is naturally found in thyme leaves. This will allow our yeast consumers to alleviate damage and destroy parasitic worms in the intestines. Our initial goal is to create a proof of concept in the lab. To do this, we followed the engineering design cycle to build our project:</p>
 
+
<br><br>
+
  
 
<ol><span style="color:black; font-weight:bold;">
 
<ol><span style="color:black; font-weight:bold;">
 
   <li>Understand the Problem </li><br>
 
   <li>Understand the Problem </li><br>
   <li>Research and Ideate Solutions: Identifying cellulases </li><br>
+
   <li>Research and Ideate Solutions: Identifying Thymol </li><br>
 
   <li>Design Solutions: Part design </li><br>
 
   <li>Design Solutions: Part design </li><br>
 
   <li>Design Solutions: Experimental design </li><br>
 
   <li>Design Solutions: Experimental design </li><br>
   <li>Create and Test: Preliminary Cellulase Testing </li><br>
+
   <li>Create and Test: Thymol Testing </li><br>
 
   <li> Evaluate </li>
 
   <li> Evaluate </li>
</span></ol></p>
+
</span></ol>
 
+
<br>
  
 
          
 
          
Line 205: Line 201:
  
 
<center><img style="width:60%;"src="https://static.igem.org/mediawiki/2020/d/d3/T--Calgary--Thymol_and_parasite.png">
 
<center><img style="width:60%;"src="https://static.igem.org/mediawiki/2020/d/d3/T--Calgary--Thymol_and_parasite.png">
<p><center><p style="color:grey; font-size: 85%;"> Figure 1. Intestinal parasites (left) and the molecular structure of thymol (right). </p></center>
+
<p style="color:grey; font-size: 85%;"> <center style="color:grey; font-size: 85%;">Figure 1. Intestinal parasites (left) and the molecular structure of thymol (right). </center>
 
<br>
 
<br>
  
Line 221: Line 217:
 
         Mass-supplementation of Vitamin A  to deficient regions have been ongoing for decades.However, even with biannual vitamin A supplementation for children and biofortified crops such as golden rice, intestinal parasites still play the villain in preventing the vitamin’s assimilation by perforating the intestines. Organizations such as the UN, WHO, and the Bill Gates Foundation couple biannual vitamin supplementation with deworming using agents like albendazole and mebendazole, but lack of clean water and proper footwear allow these parasites to return and thrive in the intestines. </p>
 
         Mass-supplementation of Vitamin A  to deficient regions have been ongoing for decades.However, even with biannual vitamin A supplementation for children and biofortified crops such as golden rice, intestinal parasites still play the villain in preventing the vitamin’s assimilation by perforating the intestines. Organizations such as the UN, WHO, and the Bill Gates Foundation couple biannual vitamin supplementation with deworming using agents like albendazole and mebendazole, but lack of clean water and proper footwear allow these parasites to return and thrive in the intestines. </p>
  
<p>Parasitic worms are among the most widespread human infections to date, affecting 2 billion people worldwide. The most common of these are Ascaris lumbricoides or the giant roundworm, hookworms, and Trichuris trichiura or the human whipworm. These worms may be obtained from direct contact with the soil, or through improper measures in hygiene. These worms cause a variety of symptoms such as stunted growth, decreased metabolic rates, physical and mental fatigue, and malnutrition (Kumar, Jain, & Jain, 2014). Since these parasites perforate the intestines, nutrition absorption is severely inhibited, causing several micronutrient supplementation programs to falter. </p>
+
<p>Parasitic worms are among the most widespread human infections to date, affecting 2 billion people worldwide. The most common of these are <span style="font-style:italic">Ascaris lumbricoides</span> or the giant roundworm, hookworms, and <span style="font-style:italic">Trichuris trichiura</span> or the human whipworm. These worms may be obtained from direct contact with the soil, or through improper measures in hygiene. These worms cause a variety of symptoms such as stunted growth, decreased metabolic rates, physical and mental fatigue, and malnutrition (Kumar, Jain, & Jain, 2014). Since these parasites perforate the intestines, nutrition absorption is severely inhibited, causing several micronutrient supplementation programs to falter. </p>
  
 
<p>Albendazole has been used as an effective cure for intestinal worm infections. When treating roundworms it has a cure rate of 98.9% and egg reduction rates of 99.6%. For hookworms, it is 56.8% and 97.7% respectively, while in whipworms it is 10.% and 73.3%. However, even with these highly effective drugs the worms return and thrive until the next round of deworming because of poor hygiene due to lack of access to clean water and proper footwear. </p>
 
<p>Albendazole has been used as an effective cure for intestinal worm infections. When treating roundworms it has a cure rate of 98.9% and egg reduction rates of 99.6%. For hookworms, it is 56.8% and 97.7% respectively, while in whipworms it is 10.% and 73.3%. However, even with these highly effective drugs the worms return and thrive until the next round of deworming because of poor hygiene due to lack of access to clean water and proper footwear. </p>
Line 227: Line 223:
 
<p>Talking to Dr. John Gilleard and Dr. Paul E. Mains from the University of Calgary, we found out that these drugs were first intended for animals but were later implemented in humans. They believe that intestinal parasites will sooner or later develop drug resistances just as they have discovered in sheep and cattle models, which is why development of new treatments should be kept on the radar. </p>
 
<p>Talking to Dr. John Gilleard and Dr. Paul E. Mains from the University of Calgary, we found out that these drugs were first intended for animals but were later implemented in humans. They believe that intestinal parasites will sooner or later develop drug resistances just as they have discovered in sheep and cattle models, which is why development of new treatments should be kept on the radar. </p>
  
         </p>
+
          
  
  
Line 237: Line 233:
 
<br>
 
<br>
 
<hr>
 
<hr>
<div class = "part-design" id="part-design">
+
<div class = "identifying-thymol" id="identifying-thymol">
 
         <h2>IDENTIFYING THYMOL</h2>
 
         <h2>IDENTIFYING THYMOL</h2>
 
         <h4>Why produce an anthelmintic?</h4>
 
         <h4>Why produce an anthelmintic?</h4>
Line 243: Line 239:
 
           For this part of the project, we initially intended to produce omega-3 fatty acids such as eicosapentaenoic acid (EPA) which has cognitive benefits to improve the nutritional value of our yeast. We learned from Dr. Dia Sanou and Lourlin Ugdiman, two public health experts who have worked in Africa and the Philippines, that producing a safe and supplementary anthelmintic as a temporary measure is a better use of our efforts. That temporary measure would be sufficient until the next round of deworming. </p>
 
           For this part of the project, we initially intended to produce omega-3 fatty acids such as eicosapentaenoic acid (EPA) which has cognitive benefits to improve the nutritional value of our yeast. We learned from Dr. Dia Sanou and Lourlin Ugdiman, two public health experts who have worked in Africa and the Philippines, that producing a safe and supplementary anthelmintic as a temporary measure is a better use of our efforts. That temporary measure would be sufficient until the next round of deworming. </p>
  
<p>Our team started looking for plant-based compounds with promising effects for anthelmintics against nematodes. We came across thymol, a compound which is the primary component in thyme oil. Thymol has been used with epsom salts to cure hookworm infections in rural schoolchildren as early as 1912. Half a gram would be administered to children ages 1-5 and a gram for those aged 5-10 (Rural School and Hookworm Disease p. 12, 1970). In modern times, the compound can be found in products such as soaps, disinfectants to pesticides, and in anti-inflammatories.  It is labeled to be safe for ingestion with “negligible toxicity” by the USFDA in humans. However, in high doses it may cause burning pain in the oesophagus, nausea, abdominal pain, vomiting, and dizziness [CITE DATASHEET].
+
<p>Our team started looking for plant-based compounds with promising effects for anthelmintics against nematodes. We came across thymol, a compound which is the primary component in thyme oil. Thymol has been used with epsom salts to cure hookworm infections in rural schoolchildren as early as 1912. Half a gram would be administered to children ages 1-5 and a gram for those aged 5-10 (Rural School and Hookworm Disease p. 12, 1970). In modern times, the compound can be found in products such as soaps, disinfectants to pesticides, and in anti-inflammatories.  It is labeled to be safe for ingestion with “negligible toxicity” by the USFDA in humans. However, in high doses it may cause burning pain in the oesophagus, nausea, abdominal pain, vomiting, and dizziness.
 
         </p>
 
         </p>
  
<center><img style="width:50%;"src="https://static.igem.org/mediawiki/2020/a/a3/T--Calgary--thymolpathway.png" /> </center>
+
<p>Thymol has been found to be <b>generally safe for consumption</b> in diluted forms. In regards to human consumption, thymol persists in the blood plasma for an average of 38 hours, with its half-life being 10.2 hours. Since the compound is lipophilic, it is absorbed quickly in the upper gut within 20 minutes of ingestion (Kohlert et al. 2002) . This works in conjunction with our yeast which is oleaginous in nature. In an oral toxicity study, the LD50 of thymol in rats was 980mg/kg which is much higher compared to other products such as caffeine of vitamin D which have 200mg/kg and 10mg/kg of LD50 respectively. Another study found no adverse effects on gross pathology and hematology when mice were supplemented with 300mg/kg per day of thymol in their diet for 19 weeks (Xie et al. 2019). These studies are important because drug trials always start in rat and mice models before moving to human trials. Further, they provide crucial information to consider in our <b>part design. </b></p>
 +
</div>
 +
 
 +
<br>
 +
<hr>
 +
<div class = "part-design" id="part-design">
 +
        <h2>PART DESIGN</h2>
 +
     
 +
        <p>
 +
        Thymol has been previously expressed in microbial systems such as <span style="font-style:italic">S.cerivisiae</span> (Aly and Abo-Sereih 2020). Since thymol is a simple monoterpenoid, its expression in <span style="font-style:italic">Yarrowia lipolytica</span> would not be too complex. This is because the organism is capable of producing geranyl diphosphate through the non-mevalonate (MEP) pathway, and would only need two additional genes to produce thymol. These genes are the <b>TvTPS1 terpene synthase</b> gene and the <b>CYP71D178 cytochrome P450 </b>gene  from <span style="font-style:italic">Thymus vulgaris</span>, better known as thyme.
 +
 
 +
        </p>
 +
<center><img style="width:70%;"src="https://static.igem.org/mediawiki/2020/a/a3/T--Calgary--thymolpathway.png" /> </center>
 +
 
 +
<h4>Gauging Thymol Production Levels</h4>
 +
<p>Since <a href="Human_Practices">Dr. Gupta</a> advised us to observe more precaution with regards to the safety and efficacy of thymol, we will test the expression of the proteins under the control of two different promoters. Our first promoter is the <b>Translation Elongation Factor 1 (TEF1) promoter </b> which is a well-known strong constitutive promoter in <span style="font-style:italic">Y. lipolytica</span> (Hong et al. 2012). Our second promoter is the <b>Proline Dehydrogenase 2 (POX2) promoter </b> which is known to be a relatively weaker promoter in <span style="font-style:italic">Y. lipolytica</span> (Shabir Hussain et al. 2017). In the future when we express thymol in <span style="font-style:italic">Y. lipolytica</span>, we will quantify its production and determine which is better suited to our end users’ safety.</p>
 +
 
 +
 
 +
<p>We have not developed parts for thymol production yet, but our construct design will follow that of <a href="Cellulase _Engineering">cellulase engineering</a> and will be assembled through Gibson assembly, except without a signal peptide. This is because we do not need to secrete thymol as it is meant to be consumed as part of the yeast. For a more detailed description of our construct design, <a href="https://2020.igem.org/Team:Calgary/Cellulase_Engineering">please click here</a>.
 +
 
 +
<p> For our proof-of-concept, we will be cloning and expressing this construct containing both TvTPS1 and CYP71D178 without any cellulases in <span style="font-style:italic">Y. lipolytica</span>. Once we have proven its functionality, we will then include these genes to our third <span style="font-style:italic">Y. lipolytica</span> strain containing the NpBGS using Gibson Assembly. </p>
 +
 
 
</div>
 
</div>
 
<br>
 
<br>
Line 253: Line 270:
 
         <h2>EXPERIMENTAL DESIGN</h2> </div>
 
         <h2>EXPERIMENTAL DESIGN</h2> </div>
 
         <h4>Thoughtful design of experiments</h4>
 
         <h4>Thoughtful design of experiments</h4>
<p> Add a blurb </p>
+
<p> Below are detailed descriptions of the planned steps/experiments we will conduct to integrate the cellulase enzymes into the <span style="font-style:italic">Y. lipolytica</span> genome. Our first experiments will be carried out in <span style="font-style:italic">Escherichia coli</span> DH5α for cloning and Gibson Assembly, after which the gene cassettes will be introduced to <span style="font-style:italic">Y. lipolytica</span>. The experimental workflow will follow the depiction in figure 5.</p>
  
 
<img style="width:100%;"src="https://static.igem.org/mediawiki/2020/6/6d/T--Calgary--Thymolworkflow.png" />  
 
<img style="width:100%;"src="https://static.igem.org/mediawiki/2020/6/6d/T--Calgary--Thymolworkflow.png" />  
 
+
<p style="color:grey; font-size: 85%;"> <center style="color:grey; font-size: 85%;">Figure 5. Experimental workflow of thymol production into  <span style="font-style:italic">Y. lipolytica</span>.</center>
 
         </p>
 
         </p>
 
<!--ACCORDION -->
 
<!--ACCORDION -->
Line 265: Line 282:
 
       <h2 class="mb-0">
 
       <h2 class="mb-0">
 
         <button class="btn btn-link" type="button" data-toggle="collapse" data-target="#collapseOne" aria-expanded="true" aria-controls="collapseOne">
 
         <button class="btn btn-link" type="button" data-toggle="collapse" data-target="#collapseOne" aria-expanded="true" aria-controls="collapseOne">
           Cloning
+
           Gibson Assembly
 
         </button>
 
         </button>
 
       </h2>
 
       </h2>
Line 272: Line 289:
 
     <div id="collapseOne" class="collapse show" aria-labelledby="headingOne" data-parent="#accordionExample">
 
     <div id="collapseOne" class="collapse show" aria-labelledby="headingOne" data-parent="#accordionExample">
 
       <div class="card-body">
 
       <div class="card-body">
         To express thymol in Yarrowia lipolytica a terpene synthase (TvTPS1) and a cytochrome P450 (CYP71D178) will be introduced. To keep substantial DNA stocks we will first transform our constructs in pSB1A3 into chemically competent Escherichia coli DH5α. This DNA would then be extracted through plasmid miniprep. Since Y. lipolytica functions best with non-homologous end joining, we will linearize the plasmid from E. coli with (insert restriction enzyme here) then transform it into Y. lipolytica using lithium acetate transformation which will result in random integration into its genome.  
+
         <p> To express thymol in <span style="font-style:italic">Y. lipolytica</span> a terpene synthase (TvTPS1) and a cytochrome P450 (CYP71D178) will be introduced. They will be assembled into the gene cassette using Gibson Assembly. The resulting Gibson plasmids will be transformed into <span style="font-style:italic">E. coli</span> for propagation and plasmid amplification. Following extraction, the plasmids will then be linearized with NotI, gel purified, and each will be transformed into a <span style="font-style:italic">Y. lipolytica</span> competent cell aliquot using the lithium acetate method to create the three strains. </p>
 +
 
 +
<p> If these gene cassettes are unable to be made after several attempts and troubleshooting to change the DNA concentrations/reaction conditions, then these cassettes can be assembled in many different ways, including sequentially. It is important to note that the TvTPS1 and CYP71D178 constructs are not submitted this year, but will be for iGEM 2021. Check out the <a href="Appendix">appendix page</a> and the <a href="Part_Collection">part collection page</a> to learn more or see the different kinds of plasmids that can be produced with our collection. </p>
 
       </div>
 
       </div>
 
     </div>
 
     </div>
Line 280: Line 299:
 
       <h2 class="mb-0">
 
       <h2 class="mb-0">
 
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo">
 
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo">
           CONFIRMATION OF THYMOL PRODUCTION/ ENZYME CHARACTERIZATION
+
           <span style="font-style:italic">Y. lipolytica</span> transformation and cPCR
 
         </button>
 
         </button>
 
       </h2>
 
       </h2>
Line 286: Line 305:
 
     <div id="collapseTwo" class="collapse" aria-labelledby="headingTwo" data-parent="#accordionExample">
 
     <div id="collapseTwo" class="collapse" aria-labelledby="headingTwo" data-parent="#accordionExample">
 
       <div class="card-body">
 
       <div class="card-body">
        Can still express in E. coli even though it’s codon-optimized for Yarrowia lipolytica.  
+
      <p> We were very fortunate to be given protocols for transformation of DNA into <span style="font-style:italic">Y. lipolytica</span> by <a href="Human_Practices">Dr. Rodrigo Ledesma-Amaro.</a> As per this protocol, cells will be made chemically competent using lithium acetate and transformed with the linearized gene cassettes containing nourseothricin as a selection marker. If the transformation is successful, we expect colonies to develop when plated on YPD with nourseothricin. If this method does not work upon changing the concentration of DNA or incubation periods, other protocols using electroporation may give higher success rates.</p>
  
Ni-NTA purification
+
<p>Colonies that appear on the nourseothricin plate will undergo colony PCR (cPCR) to verify the integration of the insert into the genome. The parts were designed to be verified using the following primers:</p>
  
Western Blot
+
<p>Forward Primer: 5’ GCTTGCTAATGTTAAGTCTCTGC 3’</p>
 +
<p>Reverse Primer: 5’ GGATTCACATCAGTCAATCACC 3’</p>
  
Bradford Assay
+
<p>We will run the PCR products on a 1% gel electrophoresis. The virtual gel below shows the expected results of the gel.</p>
  
TvTPS1
+
<center><img class="img-fluid"style="width:40%; font-color:grey;"src="https://static.igem.org/mediawiki/2020/6/60/T--Calgary--Thymolcpcr.jpeg" /></center>
To characterize the TvTPS1 gene, just add GPP.  
+
<br>
Then check absorbance values ?
+
<p style="font-size: 85%; color: grey;">Figure 6. Virtual gel showing the results of a <span style="font-style: italic;class="italic">Yarrowia lipolytica</span> cPCR upon transformation with the thymol gene cassettes. The first lane contains ddH2O. The second lane contains an empty PSB1A3 vector (expected band size = 2155bp).The stand-alone strain contains TvTPS1 + CYP71D178 + Nourseothricin resistance (expected band size= 4155p), and strain 3 contains  TvTPS1 + CYP71D178 +NpBGS + Nourseothricin resistance (expected band size= 8117bp). Ladder depicted is the Thermo Scientific GeneRuler 1 kb Plus DNA Ladder. </p>
  
CYP71D178
 
Gamma-Terpinene.
 
  
 
       </div>
 
       </div>
Line 308: Line 326:
 
       <h2 class="mb-0">
 
       <h2 class="mb-0">
 
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseThree" aria-expanded="false" aria-controls="collapseThree">
 
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseThree" aria-expanded="false" aria-controls="collapseThree">
           CAENORHABDITIS ELEGANS TESTING
+
           SDS-PAGE
 
         </button>
 
         </button>
 
       </h2>
 
       </h2>
Line 314: Line 332:
 
     <div id="collapseThree" class="collapse" aria-labelledby="headingThree" data-parent="#accordionExample">
 
     <div id="collapseThree" class="collapse" aria-labelledby="headingThree" data-parent="#accordionExample">
 
       <div class="card-body">
 
       <div class="card-body">
         Caenorhabditis elegans is the gold-standard for testing anthelmintic drugs extensively before its clinical trials in humans. To prove thymol’s activity we will be testing its effects on C. elegans by soaking Escherichia coli in varying thymol concentrations, then feed it to the C. elegans.  (Observe movement for four days. ).  Need to know which concentrations are lethal, how much our
+
         <p>SDS PAGE gels provide a qualitative verification of protein production. We will use them to confirm that our terpene synthase and cytochrome P450 proteins are being expressed. Since both proteins will not be secreted, we will be testing our cell lysate only.</p>
  
      </div>
+
<p> A 10% SDS PAGE will be run with the following expected results:</p>
    </div>
+
  </div>
+
<div class="card">
+
    <div class="card-header" id="headingFour">
+
      <h2 class="mb-0">
+
        <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseFour" aria-expanded="false" aria-controls="collapseFour">
+
          Experiment 4
+
        </button>
+
      </h2>
+
    </div>
+
    <div id="collapseFour" class="collapse" aria-labelledby="headingFour" data-parent="#accordionExample">
+
      <div class="card-body">
+
        Anim pariatur cliche reprehenderit, enim eiusmod high life accusamus terry richardson ad squid. 3 wolf moon officia aute, non cupidatat skateboard dolor brunch. Food truck quinoa nesciunt laborum eiusmod. Brunch 3 wolf moon tempor, sunt aliqua put a bird on it squid single-origin coffee nulla assumenda shoreditch et. Nihil anim keffiyeh helvetica, craft beer labore wes anderson cred nesciunt sapiente ea proident. Ad vegan excepteur butcher vice lomo. Leggings occaecat craft beer farm-to-table, raw denim aesthetic synth nesciunt you probably haven't heard of them accusamus labore sustainable VHS.
+
      </div>
+
    </div>
+
  </div>
+
  
 +
<p style="font-size: 85%; color: grey;">Table 2. Expected band sizes seen on a 10% SDS page for engineered <span style="font-style: italic;class="italic">Yarrowia lipolytica</span> standalone strain and strain 3. The stand-alone strain contains TvTPS1 + CYP71D178 + Nourseothricin resistance. Strain 3 contains  TvTPS1 + CYP71D178 +NpBGS + Nourseothricin resistance Two negative controls include <span style="font-style: italic;class="italic">Y. lipolytica</span> transformed with only Nourseothricin resistance, and untransformed <span style="font-style: italic;class="italic">Y. lipolytica</span> </p>
  
 +
<center><table width="82%">
 +
<tbody>
 +
<tr>
 +
<td width="100" bgcolor="#383030">
 +
<p style= "color:white; font-weight: bold;">Sample</p>
 +
</td>
 +
<td width="100" bgcolor="#383030">
 +
<p style= "color:white; font-weight: bold;">Expected Band for Cell Lysate</p>
  
 +
</tr>
  
  
 +
<tr>
 +
<td width="100">
 +
<p>Standalone Strain</p>
 +
<ul>
 +
<li> TvTPS1 construct</li>
 +
<li>CYP71D178 construct</li>
 +
<li>BBa_K3629015 (nourseothricin construct)</li>
 +
<ul>
 +
</td>
 +
<td width="100">
 +
<p>Bands at:</p>
 +
<ul>
 +
  <li> 60.1 kDa</li>
 +
  <li> 59.5 kDa</li>
 +
  <li> 20.4 kDa</li>
 +
</ul>
 +
</td>
  
</div> <!--Everything above this is in the ACCORDION. So copy and paste a new experiment above here. -->
+
<tr>
 +
<td width="100">
 +
<p>Strain 3</p>
 +
<ul>
 +
<li>BBa_K3629018 (NpBGS construct)</li>
 +
<li> TvTPS1 construct</li>
 +
<li>CYP71D178 construct</li>
 +
<li>BBa_K3629015 (nourseothricin construct)</li>
 +
</ul>
 +
</td>
 +
<td width="100">
 +
<p>Bands at:</p>
 +
<ul>
 +
  <li>83.0 kDa</li>
 +
<li> 60.1 kDa</li>
 +
  <li> 59.5 kDa</li>
 +
  <li>20.4 kDa</li>
 +
</ul>
 +
</td>
  
<br>
+
<tr>
<hr>
+
<td width="100">
<div class = "expected-results" id="expected-results">
+
<p>Negative control:&nbsp; <span style="font-style:italic">Y. lipolytica</span>+ Nourseothricin</p>
        <h2>Expected Results</h2>
+
</td>
        <h4>For when we get back to the lab</h4>
+
<td width="100">
 +
<p>Band at 20.4 kDa</p>
 +
</td>
 +
</tr>
  
        <p>
+
<td width="100">
          In order to provide a sustainable, community-based solution, we plan
+
<p>Negative control: Untransformed <span style="font-style:italic">Y. lipolytica</span></p>
          to genetically modify <i>Rhodosporidium toruloides</i>, an oleaginous
+
</td>
          yeast that naturally produces beta-carotene and lipids, to be more
+
<td width="100">
          robust and resource-efficient. By modifying the yeast to produce
+
<p>No bands corresponding to our recombinant proteins</p>
          cellulase, it can then use common agricultural waste products as an
+
</td>
          energy source for synthesizing its oil. It can then be eaten as a
+
</tr>
          vitamin A supplement. The yeast strain, while naturally safe and
+
</tbody>
          non-pathogenic, will also be genetically modified to include a kill
+
</table>
          switch for bio-containment, and optimized for oil production.
+
</center>
        </p>
+
<!--ACCORDION -->
+
 
+
<div class="accordion" id="accordionExample">
+
  <div class="card">
+
    <div class="card-header" id="headingOne">
+
      <h2 class="mb-0">
+
        <button class="btn btn-link" type="button" data-toggle="collapse" data-target="#collapseOne" aria-expanded="true" aria-controls="collapseOne">
+
          Cloning
+
        </button>
+
      </h2>
+
    </div>
+
 
+
    <div id="collapseOne" class="collapse show" aria-labelledby="headingOne" data-parent="#accordionExample">
+
      <div class="card-body">
+
        To express thymol in Yarrowia lipolytica a terpene synthase (TvTPS1) and a cytochrome P450 (CYP71D178) will be introduced. To keep substantial DNA stocks we will first transform our constructs in pSB1A3 into chemically competent Escherichia coli DH5α. This DNA would then be extracted through plasmid miniprep. Since Y. lipolytica functions best with non-homologous end joining, we will linearize the plasmid from E. coli with (insert restriction enzyme here) then transform it into Y. lipolytica using lithium acetate transformation which will result in random integration into its genome.
+
 
       </div>
 
       </div>
 
     </div>
 
     </div>
 
   </div>
 
   </div>
  <div class="card">
+
<div class="card">
     <div class="card-header" id="headingTwo">
+
 
 +
 
 +
<div class="card">
 +
     <div class="card-header" id="headingFour">
 
       <h2 class="mb-0">
 
       <h2 class="mb-0">
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseTwo" aria-expanded="false" aria-controls="collapseTwo">
+
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseFour" aria-expanded="false" aria-controls="collapseFour">
           CONFIRMATION OF THYMOL PRODUCTION/ ENZYME CHARACTERIZATION
+
           GC/MS
 +
 
 +
 
 
         </button>
 
         </button>
 
       </h2>
 
       </h2>
 
     </div>
 
     </div>
     <div id="collapseTwo" class="collapse" aria-labelledby="headingTwo" data-parent="#accordionExample">
+
     <div id="collapseFour" class="collapse" aria-labelledby="headingFour" data-parent="#accordionExample">
 
       <div class="card-body">
 
       <div class="card-body">
         Can still express in E. coli even though it’s codon-optimized for Yarrowia lipolytica.  
+
         <p> Gas chromatography–mass spectrometry (GC-MS) is an analytical combining the features of gas-chromatography and mass spectrometry to identify different substances and abundance within a test sample. We are using this method as it is more accurate compared to spectophotometry methods.</p>
  
Ni-NTA purification
+
<center><img class="img-fluid"style="width:40%; font-color:grey;"src="https://static.igem.org/mediawiki/2020/3/32/T--Calgary--gcms.jpeg" /></center>
  
Western Blot
+
<p style="font-size: 85%; color: grey;">Figure 7. Expected GC/MS results of <span style="font-style: italic;class="italic">Yarrowia lipolytica</span> upon transformation with the thymol gene cassettes. Retention time for thymol is 15.819 minutes while gamma-terpinene is 7.5 minutes. These are based on experiments by Raskovic et al. 2015 and Sigma Aldrich SLB®-IL59 analysis.</p>
 
+
Bradford Assay
+
 
+
TvTPS1
+
To characterize the TvTPS1 gene, just add GPP.  
+
Then check absorbance values ?
+
 
+
CYP71D178
+
Gamma-Terpinene.  
+
  
 
       </div>
 
       </div>
 
     </div>
 
     </div>
 
   </div>
 
   </div>
  <div class="card">
+
 
     <div class="card-header" id="headingThree">
+
<div class="card">
 +
     <div class="card-header" id="headingFive">
 
       <h2 class="mb-0">
 
       <h2 class="mb-0">
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseThree" aria-expanded="false" aria-controls="collapseThree">
+
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseFive" aria-expanded="false" aria-controls="collapseFive">
           CAENORHABDITIS ELEGANS TESTING
+
           Thymol Testing
 
         </button>
 
         </button>
 
       </h2>
 
       </h2>
 
     </div>
 
     </div>
     <div id="collapseThree" class="collapse" aria-labelledby="headingThree" data-parent="#accordionExample">
+
     <div id="collapseFive" class="collapse" aria-labelledby="headingFive" data-parent="#accordionExample">
 
       <div class="card-body">
 
       <div class="card-body">
         Caenorhabditis elegans is the gold-standard for testing anthelmintic drugs extensively before its clinical trials in humans. To prove thymol’s activity we will be testing its effects on C. elegans by soaking Escherichia coli in varying thymol concentrations, then feed it to the C. elegans. (Observe movement for four days. )Need to know which concentrations are lethal, how much our
+
         <p> To perform this test we will be applying standard thymol powder at different concentrations to <span style="font-style:italic">Caenorhabditis elgans</span> and <span style="font-style:italic">Ascaris lumbricoides</span> and determine their growth over four days. This is because <span style="font-style:italic">A. lumbricoides</span> are some of the most common worms affecting our target demographic while <span style="font-style:italic">C. elegans</span> is used as the gold standard for anthelmintic testing. </p>
 +
 
 +
<p> For <span style="font-style:italic">C. elegans</span>, we expect a 43% mortality-rate after growing on 100nM thymol, and 100% mortality-rate in 10,000nM in Nematode Growth Media plates. This is in reference to the data collected by Marjanovic et al. in 2018, but our <span style="font-style:italic">C. elegans</span> strain from Dr. Mains' laboratory may produce varying results</p>
  
 +
<p> As for <span style="font-style:italic">A. lumbricoides</span>, we are uncertain of the results because thymol's effects have only been tested in the relative species A. suum in pigs and not in a petri dish. The study by Kaplan et al. in 2012 show 76.8% reduction in total worm counts of pigs administered with 1.0mg/kg thymol over four weeks.  </p>
 
       </div>
 
       </div>
 
     </div>
 
     </div>
 
   </div>
 
   </div>
 +
 +
 
<div class="card">
 
<div class="card">
     <div class="card-header" id="headingFour">
+
     <div class="card-header" id="headingSix">
 
       <h2 class="mb-0">
 
       <h2 class="mb-0">
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseFour" aria-expanded="false" aria-controls="collapseFour">
+
         <button class="btn btn-link collapsed" type="button" data-toggle="collapse" data-target="#collapseSix" aria-expanded="false" aria-controls="collapseSix">
           Western Blot
+
           Co-culturing Experiments
 
         </button>
 
         </button>
 
       </h2>
 
       </h2>
 
     </div>
 
     </div>
     <div id="collapseFour" class="collapse" aria-labelledby="headingFour" data-parent="#accordionExample">
+
     <div id="collapseSix" class="collapse" aria-labelledby="headingSix" data-parent="#accordionExample">
 
       <div class="card-body">
 
       <div class="card-body">
        Anim pariatur cliche reprehenderit, enim eiusmod high life accusamus terry richardson ad squid. 3 wolf moon officia aute, non cupidatat skateboard dolor brunch. Food truck quinoa nesciunt laborum eiusmod. Brunch 3 wolf moon tempor, sunt aliqua put a bird on it squid single-origin coffee nulla assumenda shoreditch et. Nihil anim keffiyeh helvetica, craft beer labore wes anderson cred nesciunt sapiente ea proident. Ad vegan excepteur butcher vice lomo. Leggings occaecat craft beer farm-to-table, raw denim aesthetic synth nesciunt you probably haven't heard of them accusamus labore sustainable VHS.
+
      <p> Our next step is to co-culture the strains in the same media and measure the amount of thymol and gamma-terpinene again using GC/MS. We will also measure the presence of each strain to ensure that no strain is outcompeting the others. To do this, we can integrate a different reporter genes into each strain and measure the fluorescence at different wavelengths, providing a quantitative measure of the quantity of each strain in the co-culture. For more information on this assay check out our <a href="https://2020.igem.org/Team:Calgary/Biocontainment_Engineering">Bioncontainment project. </a> </p>
 
       </div>
 
       </div>
 
     </div>
 
     </div>
 
   </div>
 
   </div>
 +
  
  
Line 440: Line 477:
  
 
</div> <!--Everything above this is in the ACCORDION. So copy and paste a new experiment above here. -->
 
</div> <!--Everything above this is in the ACCORDION. So copy and paste a new experiment above here. -->
</div>
+
 
 +
 
 
<hr>
 
<hr>
 
<div class = "Future Directions" id="future-directions">
 
<div class = "Future Directions" id="future-directions">
 
         <h2>FUTURE DIRECTIONS</h2>
 
         <h2>FUTURE DIRECTIONS</h2>
         <h4>Next Steps</h4>
+
         <h4>What we've achieved this year</h4>
        <p>
+
<p>  
          In order to provide a sustainable, community-based solution, we plan
+
 
          to genetically modify <i>Rhodosporidium toruloides</i>, an oleaginous
+
&#10004; Collected our reagents and <span style="font-style:italic">C. elegans</span> for testing <br>
          yeast that naturally produces beta-carotene and lipids, to be more
+
 
          robust and resource-efficient. By modifying the yeast to produce
+
&#10004; Extensively planned all of our experiments<br>
          cellulase, it can then use common agricultural waste products as an
+
 
          energy source for synthesizing its oil. It can then be eaten as a
+
<p> &#10004; Identified promoter and gene sequences for thymol production in <span style="font-style:italic">Y. lipolytica. </span>We will be creating and codon-optimizing our constructs and have them submitted next year to contribute to the registry. </p><br>
          vitamin A supplement. The yeast strain, while naturally safe and
+
 
          non-pathogenic, will also be genetically modified to include a kill
+
<p><b>Preliminary Thymol Testing</b></p>
          switch for bio-containment, and optimized for oil production.
+
 
        </p>
+
<p>For thymol testing, we will be working with <a href="Human_Practices">Dr. Paul Mains</a> who has generously offered to perform our thymol experiments on <span style="font-style:italic">C. elegans</span> for us. We will also get our hands on <span style="font-style:italic">A. lubricoides</span> worms to determine the efficacy of our drug. </p>
 +
 
 +
<p><b>Engineering <span style="font-style:italic">Y. lipolytica</span></b></p>
 +
 
 +
<p>We will be performing the steps we have outlined in our experimental design. This time, we will be working with dry lab to create models of how thymol and our engineered yeast strain would affect the parasitic worms over time upon ingestion of Oviita. We will reach out again to <a href="Human_Practices">Dr. Christopher Naugler</a> who works with pathology informatics, and other parasitologists at the University of Calgary and beyond to optimize our system further. </p>
 +
 
 +
 
 
</div>
 
</div>
<br>
+
 
<hr>
+
 
  
  
 
<br>
 
<br>
 
<hr>
 
<hr>
<div class = "understanding-the-problem" id="understanding-the-problem">
+
<div class = "references break" id="references">
 
         <h2>References</h2>
 
         <h2>References</h2>
 
         <p>  
 
         <p>  
         Paper 1
+
         Aly, S. E.-S., & Abo-Sereih, N. A. (2020). Application of Yeast as a Bioreactor for the Production of Microbial Flavors. International Journal of Halal Research, 2(1), 40-49. https://doi.org/10.18517/ijhr.2.1.40-49.2020</p>
 +
 
 +
<p>
 +
 
 +
Kohlert, C., Schindler, G., März, R. W., Abel, G., Brinkhaus, B., Derendorf, H., Gräfe, E. U., & Veit, M. (2002). Systemic availability and pharmacokinetics of thymol in humans. Journal of clinical pharmacology, 42(7), 731–737. https://doi.org/10.1177/009127002401102678 </p>
 +
 
 +
<p>
 +
 
 +
Kumar, H., Jain, K., & Jain, R. (2014). A study of prevalence of intestinal worm infestation and efficacy of anthelmintic drugs. Medical Journal Armed Forces India, 70(2), 144-148. doi:10.1016/j.mjafi.2013.12.009 </p>
 +
 
 +
 
 +
 
 +
 
 +
 
 +
<p>
 +
 
 +
Kaplan RM, Storey BE, Vidyashankar AN, et al. Antiparasitic efficacy of a novel plant-based functional food using an Ascaris suum model in pigs. Acta Tropica. 2014 Nov;139:15-22. DOI: 10.1016/j.actatropica.2014.06.008.</p>
 +
<p>
 +
 
 +
Marjanovic, S., Bogunović, D., Milovanović, M., Marinković, D., Zdravković, N., Magaš, V., & Trailovic, M. (2018). Antihelminic Activity of Carvacrol, Thymol, Cinnamaldehyde and P-Cymen Against the Free-Living Nematode Caenorhabditis elegans and Rat Pinworm Syphacia muris. Acta Veterinaria-beograd, 68, 445-456.</p>
 +
 
 +
<p>
 +
Rašković, A., Pavlović, N., Kvrgić, M., Sudji, J., Mitić, G., Čapo, I., & Mikov, M. (2015). Effects of pharmaceutical formulations containing thyme on carbon tetrachloride-induced liver injury in rats. BMC complementary and alternative medicine, 15, 442. https://doi.org/10.1186/s12906-015-0966-z</p>
 +
 
 +
<p>
 +
Santa Cruz Biotech, “Thymol,”sc-215984.</p>
 +
<p>
 +
Shabbir Hussain, M., Wheeldon, I., & Blenner, M. A. (2017). A Strong Hybrid Fatty Acid Inducible Transcriptional Sensor Built From Yarrowia lipolytica Upstream Activating and Regulatory Sequences. Biotechnology journal, 12(10), 10.1002/biot.201700248. https://doi.org/10.1002/biot.201700248</p>
 +
 
 +
<p>
 +
The rural school and hookworm disease : Ferrell, John Atkinson, 1880- : Free Download, Borrow, and Streaming. (1970, January 01). Retrieved October 26, 2020, from https://archive.org/details/ruralschoolhookw00ferruoft/page/11/mode/2up?q=thymol</p>
 +
 
 +
<p>
 +
Vercruysse J, Behnke JM, Albonico M, Ame SM, Angebault C, Bethony JM, et al. (2011) Assessment of the Anthelmintic Efficacy of Albendazole in School Children in Seven Countries Where Soil-Transmitted Helminths Are Endemic. PLoS Negl Trop Dis 5(3): e948. https://doi.org/10.1371/journal.pntd.0000948</p>
 +
 
 +
<p>
 +
Xie, K., Tashkin, D. P., Luo, M. Z., & Zhang, J. Y. (2019). Chronic toxicity of inhaled thymol in lungs and respiratory tracts in mouse model. Pharmacology research & perspectives, 7(5), e00516. https://doi.org/10.1002/prp2.516
  
 
         </p>
 
         </p>

Latest revision as of 20:30, 19 December 2020



OVERVIEW




Optimizing Nutrient Absorption Through Anthelmintics

To allow our target communities to maximize micronutrient and vitamin A absorption in between deworming seasons, we will engineer our yeast to produce thymol which is naturally found in thyme leaves. This will allow our yeast consumers to alleviate damage and destroy parasitic worms in the intestines. Our initial goal is to create a proof of concept in the lab. To do this, we followed the engineering design cycle to build our project:

  1. Understand the Problem

  2. Research and Ideate Solutions: Identifying Thymol

  3. Design Solutions: Part design

  4. Design Solutions: Experimental design

  5. Create and Test: Thymol Testing

  6. Evaluate

Over the next year, we will be working towards a lab proof of concept for thymol testing and production. This engineering design cycle will repeat once we have accomplished this and look towards community implementation. For more information on our plans for next year and beyond iGEM, please refer to the Future Directions section.

Figure 1. Intestinal parasites (left) and the molecular structure of thymol (right).



UNDERSTANDING THE PROBLEM

Inadequate Access to Healthcare

Mass-supplementation of Vitamin A to deficient regions have been ongoing for decades.However, even with biannual vitamin A supplementation for children and biofortified crops such as golden rice, intestinal parasites still play the villain in preventing the vitamin’s assimilation by perforating the intestines. Organizations such as the UN, WHO, and the Bill Gates Foundation couple biannual vitamin supplementation with deworming using agents like albendazole and mebendazole, but lack of clean water and proper footwear allow these parasites to return and thrive in the intestines.

Parasitic worms are among the most widespread human infections to date, affecting 2 billion people worldwide. The most common of these are Ascaris lumbricoides or the giant roundworm, hookworms, and Trichuris trichiura or the human whipworm. These worms may be obtained from direct contact with the soil, or through improper measures in hygiene. These worms cause a variety of symptoms such as stunted growth, decreased metabolic rates, physical and mental fatigue, and malnutrition (Kumar, Jain, & Jain, 2014). Since these parasites perforate the intestines, nutrition absorption is severely inhibited, causing several micronutrient supplementation programs to falter.

Albendazole has been used as an effective cure for intestinal worm infections. When treating roundworms it has a cure rate of 98.9% and egg reduction rates of 99.6%. For hookworms, it is 56.8% and 97.7% respectively, while in whipworms it is 10.% and 73.3%. However, even with these highly effective drugs the worms return and thrive until the next round of deworming because of poor hygiene due to lack of access to clean water and proper footwear.

Talking to Dr. John Gilleard and Dr. Paul E. Mains from the University of Calgary, we found out that these drugs were first intended for animals but were later implemented in humans. They believe that intestinal parasites will sooner or later develop drug resistances just as they have discovered in sheep and cattle models, which is why development of new treatments should be kept on the radar.




IDENTIFYING THYMOL

Why produce an anthelmintic?

For this part of the project, we initially intended to produce omega-3 fatty acids such as eicosapentaenoic acid (EPA) which has cognitive benefits to improve the nutritional value of our yeast. We learned from Dr. Dia Sanou and Lourlin Ugdiman, two public health experts who have worked in Africa and the Philippines, that producing a safe and supplementary anthelmintic as a temporary measure is a better use of our efforts. That temporary measure would be sufficient until the next round of deworming.

Our team started looking for plant-based compounds with promising effects for anthelmintics against nematodes. We came across thymol, a compound which is the primary component in thyme oil. Thymol has been used with epsom salts to cure hookworm infections in rural schoolchildren as early as 1912. Half a gram would be administered to children ages 1-5 and a gram for those aged 5-10 (Rural School and Hookworm Disease p. 12, 1970). In modern times, the compound can be found in products such as soaps, disinfectants to pesticides, and in anti-inflammatories. It is labeled to be safe for ingestion with “negligible toxicity” by the USFDA in humans. However, in high doses it may cause burning pain in the oesophagus, nausea, abdominal pain, vomiting, and dizziness.

Thymol has been found to be generally safe for consumption in diluted forms. In regards to human consumption, thymol persists in the blood plasma for an average of 38 hours, with its half-life being 10.2 hours. Since the compound is lipophilic, it is absorbed quickly in the upper gut within 20 minutes of ingestion (Kohlert et al. 2002) . This works in conjunction with our yeast which is oleaginous in nature. In an oral toxicity study, the LD50 of thymol in rats was 980mg/kg which is much higher compared to other products such as caffeine of vitamin D which have 200mg/kg and 10mg/kg of LD50 respectively. Another study found no adverse effects on gross pathology and hematology when mice were supplemented with 300mg/kg per day of thymol in their diet for 19 weeks (Xie et al. 2019). These studies are important because drug trials always start in rat and mice models before moving to human trials. Further, they provide crucial information to consider in our part design.



PART DESIGN

Thymol has been previously expressed in microbial systems such as S.cerivisiae (Aly and Abo-Sereih 2020). Since thymol is a simple monoterpenoid, its expression in Yarrowia lipolytica would not be too complex. This is because the organism is capable of producing geranyl diphosphate through the non-mevalonate (MEP) pathway, and would only need two additional genes to produce thymol. These genes are the TvTPS1 terpene synthase gene and the CYP71D178 cytochrome P450 gene from Thymus vulgaris, better known as thyme.

Gauging Thymol Production Levels

Since Dr. Gupta advised us to observe more precaution with regards to the safety and efficacy of thymol, we will test the expression of the proteins under the control of two different promoters. Our first promoter is the Translation Elongation Factor 1 (TEF1) promoter which is a well-known strong constitutive promoter in Y. lipolytica (Hong et al. 2012). Our second promoter is the Proline Dehydrogenase 2 (POX2) promoter which is known to be a relatively weaker promoter in Y. lipolytica (Shabir Hussain et al. 2017). In the future when we express thymol in Y. lipolytica, we will quantify its production and determine which is better suited to our end users’ safety.

We have not developed parts for thymol production yet, but our construct design will follow that of cellulase engineering and will be assembled through Gibson assembly, except without a signal peptide. This is because we do not need to secrete thymol as it is meant to be consumed as part of the yeast. For a more detailed description of our construct design, please click here.

For our proof-of-concept, we will be cloning and expressing this construct containing both TvTPS1 and CYP71D178 without any cellulases in Y. lipolytica. Once we have proven its functionality, we will then include these genes to our third Y. lipolytica strain containing the NpBGS using Gibson Assembly.



EXPERIMENTAL DESIGN

Thoughtful design of experiments

Below are detailed descriptions of the planned steps/experiments we will conduct to integrate the cellulase enzymes into the Y. lipolytica genome. Our first experiments will be carried out in Escherichia coli DH5α for cloning and Gibson Assembly, after which the gene cassettes will be introduced to Y. lipolytica. The experimental workflow will follow the depiction in figure 5.

Figure 5. Experimental workflow of thymol production into Y. lipolytica.

To express thymol in Y. lipolytica a terpene synthase (TvTPS1) and a cytochrome P450 (CYP71D178) will be introduced. They will be assembled into the gene cassette using Gibson Assembly. The resulting Gibson plasmids will be transformed into E. coli for propagation and plasmid amplification. Following extraction, the plasmids will then be linearized with NotI, gel purified, and each will be transformed into a Y. lipolytica competent cell aliquot using the lithium acetate method to create the three strains.

If these gene cassettes are unable to be made after several attempts and troubleshooting to change the DNA concentrations/reaction conditions, then these cassettes can be assembled in many different ways, including sequentially. It is important to note that the TvTPS1 and CYP71D178 constructs are not submitted this year, but will be for iGEM 2021. Check out the appendix page and the part collection page to learn more or see the different kinds of plasmids that can be produced with our collection.

We were very fortunate to be given protocols for transformation of DNA into Y. lipolytica by Dr. Rodrigo Ledesma-Amaro. As per this protocol, cells will be made chemically competent using lithium acetate and transformed with the linearized gene cassettes containing nourseothricin as a selection marker. If the transformation is successful, we expect colonies to develop when plated on YPD with nourseothricin. If this method does not work upon changing the concentration of DNA or incubation periods, other protocols using electroporation may give higher success rates.

Colonies that appear on the nourseothricin plate will undergo colony PCR (cPCR) to verify the integration of the insert into the genome. The parts were designed to be verified using the following primers:

Forward Primer: 5’ GCTTGCTAATGTTAAGTCTCTGC 3’

Reverse Primer: 5’ GGATTCACATCAGTCAATCACC 3’

We will run the PCR products on a 1% gel electrophoresis. The virtual gel below shows the expected results of the gel.


Figure 6. Virtual gel showing the results of a Yarrowia lipolytica cPCR upon transformation with the thymol gene cassettes. The first lane contains ddH2O. The second lane contains an empty PSB1A3 vector (expected band size = 2155bp).The stand-alone strain contains TvTPS1 + CYP71D178 + Nourseothricin resistance (expected band size= 4155p), and strain 3 contains TvTPS1 + CYP71D178 +NpBGS + Nourseothricin resistance (expected band size= 8117bp). Ladder depicted is the Thermo Scientific GeneRuler 1 kb Plus DNA Ladder.

SDS PAGE gels provide a qualitative verification of protein production. We will use them to confirm that our terpene synthase and cytochrome P450 proteins are being expressed. Since both proteins will not be secreted, we will be testing our cell lysate only.

A 10% SDS PAGE will be run with the following expected results:

Table 2. Expected band sizes seen on a 10% SDS page for engineered Yarrowia lipolytica standalone strain and strain 3. The stand-alone strain contains TvTPS1 + CYP71D178 + Nourseothricin resistance. Strain 3 contains TvTPS1 + CYP71D178 +NpBGS + Nourseothricin resistance Two negative controls include Y. lipolytica transformed with only Nourseothricin resistance, and untransformed Y. lipolytica

Sample

Expected Band for Cell Lysate

Standalone Strain

  • TvTPS1 construct
  • CYP71D178 construct
  • BBa_K3629015 (nourseothricin construct)

Bands at:

  • 60.1 kDa
  • 59.5 kDa
  • 20.4 kDa

Strain 3

  • BBa_K3629018 (NpBGS construct)
  • TvTPS1 construct
  • CYP71D178 construct
  • BBa_K3629015 (nourseothricin construct)

Bands at:

  • 83.0 kDa
  • 60.1 kDa
  • 59.5 kDa
  • 20.4 kDa

Negative control:  Y. lipolytica+ Nourseothricin

Band at 20.4 kDa

Negative control: Untransformed Y. lipolytica

No bands corresponding to our recombinant proteins

Gas chromatography–mass spectrometry (GC-MS) is an analytical combining the features of gas-chromatography and mass spectrometry to identify different substances and abundance within a test sample. We are using this method as it is more accurate compared to spectophotometry methods.

Figure 7. Expected GC/MS results of Yarrowia lipolytica upon transformation with the thymol gene cassettes. Retention time for thymol is 15.819 minutes while gamma-terpinene is 7.5 minutes. These are based on experiments by Raskovic et al. 2015 and Sigma Aldrich SLB®-IL59 analysis.

To perform this test we will be applying standard thymol powder at different concentrations to Caenorhabditis elgans and Ascaris lumbricoides and determine their growth over four days. This is because A. lumbricoides are some of the most common worms affecting our target demographic while C. elegans is used as the gold standard for anthelmintic testing.

For C. elegans, we expect a 43% mortality-rate after growing on 100nM thymol, and 100% mortality-rate in 10,000nM in Nematode Growth Media plates. This is in reference to the data collected by Marjanovic et al. in 2018, but our C. elegans strain from Dr. Mains' laboratory may produce varying results.

As for A. lumbricoides, we are uncertain of the results because thymol's effects have only been tested in the relative species A. suum in pigs and not in a petri dish. The study by Kaplan et al. in 2012 show 76.8% reduction in total worm counts of pigs administered with 1.0mg/kg thymol over four weeks.

Our next step is to co-culture the strains in the same media and measure the amount of thymol and gamma-terpinene again using GC/MS. We will also measure the presence of each strain to ensure that no strain is outcompeting the others. To do this, we can integrate a different reporter genes into each strain and measure the fluorescence at different wavelengths, providing a quantitative measure of the quantity of each strain in the co-culture. For more information on this assay check out our Bioncontainment project.


FUTURE DIRECTIONS

What we've achieved this year

✔ Collected our reagents and C. elegans for testing
✔ Extensively planned all of our experiments

✔ Identified promoter and gene sequences for thymol production in Y. lipolytica. We will be creating and codon-optimizing our constructs and have them submitted next year to contribute to the registry.


Preliminary Thymol Testing

For thymol testing, we will be working with Dr. Paul Mains who has generously offered to perform our thymol experiments on C. elegans for us. We will also get our hands on A. lubricoides worms to determine the efficacy of our drug.

Engineering Y. lipolytica

We will be performing the steps we have outlined in our experimental design. This time, we will be working with dry lab to create models of how thymol and our engineered yeast strain would affect the parasitic worms over time upon ingestion of Oviita. We will reach out again to Dr. Christopher Naugler who works with pathology informatics, and other parasitologists at the University of Calgary and beyond to optimize our system further.



References

Aly, S. E.-S., & Abo-Sereih, N. A. (2020). Application of Yeast as a Bioreactor for the Production of Microbial Flavors. International Journal of Halal Research, 2(1), 40-49. https://doi.org/10.18517/ijhr.2.1.40-49.2020

Kohlert, C., Schindler, G., März, R. W., Abel, G., Brinkhaus, B., Derendorf, H., Gräfe, E. U., & Veit, M. (2002). Systemic availability and pharmacokinetics of thymol in humans. Journal of clinical pharmacology, 42(7), 731–737. https://doi.org/10.1177/009127002401102678

Kumar, H., Jain, K., & Jain, R. (2014). A study of prevalence of intestinal worm infestation and efficacy of anthelmintic drugs. Medical Journal Armed Forces India, 70(2), 144-148. doi:10.1016/j.mjafi.2013.12.009

Kaplan RM, Storey BE, Vidyashankar AN, et al. Antiparasitic efficacy of a novel plant-based functional food using an Ascaris suum model in pigs. Acta Tropica. 2014 Nov;139:15-22. DOI: 10.1016/j.actatropica.2014.06.008.

Marjanovic, S., Bogunović, D., Milovanović, M., Marinković, D., Zdravković, N., Magaš, V., & Trailovic, M. (2018). Antihelminic Activity of Carvacrol, Thymol, Cinnamaldehyde and P-Cymen Against the Free-Living Nematode Caenorhabditis elegans and Rat Pinworm Syphacia muris. Acta Veterinaria-beograd, 68, 445-456.

Rašković, A., Pavlović, N., Kvrgić, M., Sudji, J., Mitić, G., Čapo, I., & Mikov, M. (2015). Effects of pharmaceutical formulations containing thyme on carbon tetrachloride-induced liver injury in rats. BMC complementary and alternative medicine, 15, 442. https://doi.org/10.1186/s12906-015-0966-z

Santa Cruz Biotech, “Thymol,”sc-215984.

Shabbir Hussain, M., Wheeldon, I., & Blenner, M. A. (2017). A Strong Hybrid Fatty Acid Inducible Transcriptional Sensor Built From Yarrowia lipolytica Upstream Activating and Regulatory Sequences. Biotechnology journal, 12(10), 10.1002/biot.201700248. https://doi.org/10.1002/biot.201700248

The rural school and hookworm disease : Ferrell, John Atkinson, 1880- : Free Download, Borrow, and Streaming. (1970, January 01). Retrieved October 26, 2020, from https://archive.org/details/ruralschoolhookw00ferruoft/page/11/mode/2up?q=thymol

Vercruysse J, Behnke JM, Albonico M, Ame SM, Angebault C, Bethony JM, et al. (2011) Assessment of the Anthelmintic Efficacy of Albendazole in School Children in Seven Countries Where Soil-Transmitted Helminths Are Endemic. PLoS Negl Trop Dis 5(3): e948. https://doi.org/10.1371/journal.pntd.0000948

Xie, K., Tashkin, D. P., Luo, M. Z., & Zhang, J. Y. (2019). Chronic toxicity of inhaled thymol in lungs and respiratory tracts in mouse model. Pharmacology research & perspectives, 7(5), e00516. https://doi.org/10.1002/prp2.516